Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
Isamu Okamoto(Kyushu University), Yoichi Nakanishi(Kyushu University Hospital)
Cited by 35
Related Papers
Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
|Biology Open|2017|13